1Greenblatt MS, Bennett WP,Hollstein, et al. Mutation in the P53tumor supressor gene: clue to cancer etiology andmolecular pathogonsis. Cancer Res,1994,54(18): 4855～4878
2Joypaul BV, Newan EL, Hopwood D, et al. Expression of P53 protein in normal,dysplastic, and malignant gastric mucosa: an immunohistochemical study.JPathol,1993,170(3):279～283
4Helmut EG,Wolfram M, Anke S, et al. The relationship of P53 expression to theprognosis of 418 patients with gastric carcinoma. Cancer, 1995,76(5):720～726
5Kodera Y, Lsobe KI, Yamauchi M, et al. Expression of nm23-H1 RNA levelsin humangastric cancer tissues. Cancer, 1994,73(2):259～265
6Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confersmetastatic potential to rat carcinoma cells.Cell,1991,65(1):13～24
7Heider K, Dammrich J, Skroch P, et al. Differential expression of CD44 splicevariants in intestinal and diffuse type human gastric carcinoma and normal gastric mucosa.Cancer Res, 1994,53(18):4197～4203
8Dammrich J, Vollmers HP, Heider K, et al. Importance of different CD44v6 expressionin human gastric intestinal and diffuse type cancer for metastatic lymphogenic spreading.J Mol Med,1995,73(2):395～402
9Wolfram M, Anke S, Karl H, et al. Expression and prognostic value ofthe CD44splicing variants V5 and V6 in gastric cancer. J Pathol,1997,183(2):222～227
3Potec T, Potec A, Sajin M, et al. Biological prognostic parameters in gastric careinomas [J]. Chirurgia, 2014, 109 (3) : 347-354.
4Bhardwaj V, Noto JM, Wei J, et al. Helicobacter pylori bacteria alter the p53 stress response via ERK-HDM2 pathway [J]. Oncotarget,2015,6(3) :1531-1543.
5Saf C, Gulcan EM, Ozkan F, et al. Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis[J]. Eur J Gastroenterol Hepatol, 2015,27 (2) : 155-161.
6Fuccio L, Zagari RM, Eusebi LH, et al. Meta analysis: canHelicobacter pylori eradication treatment reduce the risk for gastric cancer[J].Ann Intern Med,2009,151(2) : 121-128.
7Moradi M, Salehi Z, Aminian K, et al. Effects of p53 Codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population[J]. Asian Pac J Cancer Prey, 2014,15(17) : 7413-7417.
8Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the nonneoplastic mucosa of the human stomach showing intestinal metaplasia[J]. Int J Cancer, 1996,69(1) :28-33.
9Berloco P, Russo F, Cariola F, et al. Low presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma[J]. J Gastroenterol, 2003,38 (1) : 28- 36.
10Siegel R, Naishadham D, Jemal A. (2012) Cancer statistics [J]. CA Cancer J Clin, 2012, 62(1): 10-29.
